AI in Life Science Analytics Market Growth Drivers and Challenges:
Growth Drivers
- AI in drug research and development: AI is gaining widespread adoption including in the life science sector. AI algorithms integrate with various datasets including chemical structure, biological, data, and patient records, which further aids in drug differentiation and interaction at a molecular level. This is positively influencing the overall AI in life science analytics market growth as AI is opening new avenues for drug discovery and streamlining clinical trials.
Also, by predicting issues early and optimizing trial processes, AI helps reduce the costs associated with drug development. For instance, in September 2024, Google DeepMind launched AlphaProteo the first AI system that aids researchers in drug designing and disease understanding more effectively. - Public and private sector investments: The growing investments from both private and public sectors are significantly influencing the adoption of AI in life sciences. Governments across the world are allocating sustainable funding to research organizations and universities for AI-related life science projects. Government agencies such as the U.S. National Institutes of Health and funding and research programs including Europe Commission’s Horizon Europe are contributing to the increasing use of AI in biomedical research and healthcare.
Challenges
-
Data security and privacy concerns: AI and ML algorithms generate vast amounts of data and ensuring the confidentiality and security of this sensitive health data is most important. Attacks from cybercriminals can lead to a loss of vital data and high-profit opportunities for end users. Even though digital technologies are offering vast opportunities the concerns related to data security and privacy are expected to hamper the overall AI in life science analytics market growth to some extent.
- High investment costs: The development and installation of AI solutions require high investments in technology, infrastructure, and expertise that can be prohibitive for organizations running on tight budgets. AI applications need high-performance computing infrastructure and specialized hardware for processing large volumes of datasets, these hardware solutions are quite expensive to install and maintain.
AI in Life Science Analytics Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
14.3% |
|
Base Year Market Size (2025) |
USD 2.36 billion |
|
Forecast Year Market Size (2035) |
USD 8.98 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of AI in life science analytics is evaluated at USD 2.66 billion.
The global AI in life science analytics market size exceeded USD 2.36 billion in 2025 and is set to register a CAGR of over 14.3%, exceeding USD 8.98 billion revenue by 2035.
North America AI in life science analytics market will account for 44.50% share by 2035, driven by digital technology adoption in life science analytics and increased healthcare R&D.
Key players in the market include IBM Corporation, SAS Institute Inc., Oracle Corporation, IQVIA Inc., Accenture plc, Cognizant Technology Solutions Corporation, Wipro Limited, Palantir Technologies Inc., Saama Technologies, Inc., Tempus Labs, Inc.